Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

DPD courier 5.49 € GLS courier 10.49 €

Contact

How to shop

Help

My account

▸ Empty :-(

Advances in Prostate Cancer

Name: Advances in Prostate Cancer
Brand: In Tech
SKU: 24120764
Price: 153.94 EUR
Availability: InStock
Author: Gerhard Hamilton
ISBN: 9789535109327

Gerhard Hamilton

Language

English

Book Hardback

Libristo code: 24120764

Publishers In Tech, January 2013

Prostate cancer is one of the most common types of cancer in men and its treatment was constricted t... Full description

Libristo code: 24120764

376 b

153.94 €

In stock at our supplier Shipping in 10-13 days

Up to 30 days for returns

Customers also purchased

5 Zutaten Gottesnahrung Kochbuch: Die leckersten Rezepte der naturbelassenen Ernahrung fur jeden Geschmack und Anlass - inkl. 30-Tage-Ernahrungsplan, Klara Lindenau

Adobe ePub DRM

8.70 €

فك التعطيل خالد موسى البلوشي

Paperback

9.31 €

Ti con zero Italo Calvino

Paperback

18.42 €

Livre de Excel Word PowerPoint OneNote 2013 En poche Jean-François Sehan

Paperback

12.31 €

Gâteaux mini sucre avec Cake Factory Juliette Lalbaltry Book

Paperback

16.62 €

EN EL PRINCIPIO ERES L Y TU DESTINO FIN Aliyah ישראל

Paperback

13.21 €

Tilda Elmacekirdegi - Benim Icin Cok Degerlisin Andreas H. Schmachtl

Paperback

13.01 €

Bahnwarter Thiel Gerhart Hauptmann

Paperback

4.50 €

Il Libro del Profeta Ezechiele: Secondo Volume (Cap. 12:1-28; 23:1-49 Andrea Belli

Paperback

23.33 €

Prostate cancer is one of the most common types of cancer in men and its treatment was constricted to surgery for confined state and androgen ablation for advanced disease until new options have become available. The present book covers a broad range of novel aspects of prostate cancer diagnosis, treatment and patient care, as well as new research on relevant cell biology. In detail, this special volume focusses on supportive modalities for prostate cancer patients, appropriate selection of novel therapeutic regimens, including inhibitors of steroidal synthesis, cytotoxic agents, as well as intermittent androgen suppression and the roles of prostate cancer stem cells and inflammatory processes.